Clinical Trials Browser

OTHER × Solid Tumor, Adult × pembrolizumab × Clear all

NCT03274661 2023-10-19

Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors

Phase 2 Completed

52 enrolled 12 charts

Other solid neoplasm

Solid Tumor, Adult